Financial instruments - disclosures

12 Months Ended

Oct. 31, 2024


Note 2 6		Financial instruments – disclosures

Certain disclosures required by IFRS 7 are provided in the shaded sections of the “MD&A – Management of risk”, as permitted by IFRS. The following table provides a cross referencing of those disclosures in the MD&A.


Description		Section
For each type of risk arising from financial instruments, an entity shall disclose: the exposure to risks and how they arise; objectives, policies and processes used for managing the risks; methods used to measure the risk; and description of collateral.		Risk overview
		Credit risk
		Market risk
		Liquidity risk
		Operational risk
		Reputation and legal risks
		Conduct risk
		Regulatory compliance risk
Credit risk: gross exposure to credit risk, credit quality and concentration of exposures.		Credit risk
Market risk: trading portfolios – Value-at-Risk; non-trading portfolios – interest rate risk, foreign exchange risk and equity risk.		Market risk
Liquidity risk: liquid assets, maturity of financial assets and liabilities, and credit commitments.		Liquidity risk

We have provided quantitative disclosures related to credit risk consistent with Basel guidelines in the “Credit risk” section of the MD&A. The table below sets out the categories of the

on-balance

sheet exposures that are subject to the credit risk framework as set out in the CAR Guideline issued by OSFI under the different Basel approaches based on the carrying value of those exposures in our consolidated financial statements. The credit risk framework includes CCR exposures arising from OTC derivatives, repo-style transactions and trades cleared through CCPs, as well as securitization exposures. Items not subject to the credit risk framework include exposures that are subject to the market risk framework, amounts that are not subject to capital requirements or are subject to deduction from capital, and amounts relating to CIBC’s insurance subsidiaries, which are excluded from the scope of regulatory consolidation.


$ millions, as at October 31		IRB approach			Standardized approach			Other credit risk (1)		Securitization approach		Total subject to credit risk			Not subject to credit risk		Total consolidated balance sheet
2024	Cash and deposits with banks	$	42,869		$	2,941		$	2,254	$	–	$	48,064		$	–	$	48,064
	Securities		144,993			5,156			–		2,976		153,125			101,220		254,345
	Cash collateral on securities borrowed		15,934			1,094			–		–		17,028			–		17,028
	Securities purchased under resale agreements		56,853			–			–		1,891		58,744			24,977		83,721
	Loans		524,427			15,477			1,240		18,545		559,689			2,514		562,203
	Allowance for credit losses		(3,607	)		(310	)		–		–		(3,917	)		–		(3,917	)
	Derivative instruments		36,435			–			–		–		36,435			–		36,435
	Customers’ liability under acceptances		6			–			–		–		6			–		6
	Other assets		21,733			135			8,613		97		30,578			13,522		44,100
	Total credit exposures	$	839,643		$	24,493		$	12,107	$	23,509	$	899,752		$	142,233	$	1,041,985
2023 (2) (3)	Total credit exposures	$	774,042		$	90,815		$	10,915	$	18,168	$	893,940		$	81,750	$	975,690

(1)

Includes credit risk exposures arising from other assets that are subject to the credit risk framework but are not included in the standardized or IRB frameworks, including other balance sheet assets which are risk-weighted at 100%, significant investments in the capital of

non-financial

institutions, and amounts below the thresholds for capital deduction that are risk-weighted at 250%.

(2)	Certain prior year information has been restated to conform to the current year presentation.

(3)	Certain prior year information has been restated to reflect the adoption of IFRS 17. See Note 1 to the consolidated financial statements for additional details.